Association of maternal diseases during pregnancy with the risk of single ventricular septal defects in the offspring – a population-based case-control study

References

• Czeizel AE, Kamarás J, Balogh Ö, Szentpéteri J. Incidence of congenital heart defects in Budapest. Acta Paediat Acad Sci Hung 1982;13:191–202
   Google Scholar
• Hoffman JIE, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002;39:1890–900
   PubMed Web of Science ®Google Scholar
• Calzolary E, Garani G, Cocchi G,, et al. Congenital heart defects: 15 years of experience of the Emilia-Romagna Registry (Italy). Eur J Epidemiol 2003;18:773–80
   PubMed Web of Science ®Google Scholar
• Hoffman JIE, Kaplan S, Liberthson RR. Prevalence of congenital heart disease. Am heart J 2004;147:425–39
   PubMed Web of Science ®Google Scholar
• Dolk H. Loane M, Garne R. A European Surveillance of Congenital Anomalies (EUROCAT) Working Group. Congenital heart defects in Europe: prevalence and perinatal mortality. 2000 to 2005. Circulation 2011;123:841–9
   PubMed Web of Science ®Google Scholar
• Mészáros M, Nagy A, Czeizel AE. Incidence of congenital heart disease in Hungary. Hum Hered 1975;25:513–9
   PubMed Web of Science ®Google Scholar
• Mészáros M, Czeizel AE. Point prevalence at birth of ventricular septal defect in Hungary. Acta Paediat Acad Sci Hung 1978;19:51–4
   PubMedGoogle Scholar
• Penny DJ, Vick III, GW. Ventricular septal defect. Lancet 2011;377:1103–12
   PubMed Web of Science ®Google Scholar
• Czeizel AE, Rockenbauer M, Siffel CS, Varga E. Description and mission evaluation of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980–1996. Teratology 2001;63:176–85
   PubMedGoogle Scholar
• Vereczkey A, Kósa ZS, Csáky-Szunyogh M, et al. Birth outcomes of cases with ventricular septal defects in the function of maternal socio-demographic features – a population-based case-control study. Cent Eur J Med (in press)
   Google Scholar
• Czeizel AE The first 25 years of the Hungarian Congenital Abnormality Registry. Teratology 1997;55:299–305
   PubMedGoogle Scholar
• Czeizel AE, Intődy ZS, Modell B. What proportion of congenital abnormalities can be prevented? Brit Med J 1993;306:499–503
   PubMed Web of Science ®Google Scholar
• Czeizel AE, Petik D, Vargha P. Validation studies of drug exposures in pregnant women. Pharmacoepid Drug Safety 2003;12:409–16
   Google Scholar
• Czeizel AE, Vargha P. Periconceptional folic acid/multivitamin supplementation and twin pregnancy. Am J Obstet Gynecol 2004;191:790–4
   PubMed Web of Science ®Google Scholar
• Ács N, Bánhidy F, Puho E, Czeizel AE. Maternal influenza during pregnancy and risk of congenital abnormalities in offspring. Birth Defects Res Part A 2005;73:989–95
   PubMed Web of Science ®Google Scholar
• Ferencz C, Loffredo CA, Rubin JD, Magee CA. Epidemiology of congenital heart diseases. The Baltimore–Washington infant study: 1981–1989. Mount Kisco, NY: Future Publ Co.; 1993
   Google Scholar
• Ferencz C, Loffredo CA, Correa-Villasenor A, Wilson PD. Genetic and environmental risk factors of major cardiovascular malformations: the Baltimore–Washington infant study: 1981–1989. Armonk, NY: Future Publ. Co.; 1997
   Google Scholar
• Mitchell SC, Berendes HW, Clark WMJ. The normal closure of the ventricular septum, Am Heart J 1967;73:334–8
   PubMed Web of Science ®Google Scholar
• Czeizel AE, Puho HE, Ács N, Bánhidy F. Use of specified critical periods of different congenital abnormalities instead of the first trimester concept. Birth Defects Res Part A 2008;82:139–46
   PubMed Web of Science ®Google Scholar
• Puho E., Métneki J., Czeizel A.E. Maternal employment status and isolated orofacial clefts in Hungary. Centr Eur J Publ Health 2005;13:144–8
   PubMedGoogle Scholar
• Ács N, Bánhidy F, Puho E, Czeizel AE. Population-based case-control study of the common cold during pregnancy and congenital abnormalities. Eur J Epid 2006;21:65–76
   PubMed Web of Science ®Google Scholar
• Tikkanen J, Heinonen OP. Maternal hyperthermia during pregnancy and cardiovascular malformations in the offspring. Eur J Epid 1991;7:628–35
   PubMed Web of Science ®Google Scholar
• Botto LD, Lynberg MC, Erickson JD. Congenital heart defect, maternal febrile diseases and multivitamin use: a population-based study. Epidemiology 2001;12:485–90
   PubMed Web of Science ®Google Scholar
• Oster ME, Riehle-Colarusso T, Alverson C, Correa A. Associations between maternal fever and influenza and congenital heart defects. J Pediatr 2011;158:990–5
   PubMed Web of Science ®Google Scholar
• Czeizel AE, Ács N, Bánhidy R, et al. Primary prevention of congenital abnormalities due to high fever related maternal diseases by antifever therapy and folic acid supplementation. Curr Women’s Health Rev 2007;3:1–11
   Google Scholar
• Holmes LB, Harvey EA, Couli BA et al. The teratogenicity of anticonvulsant drugs. N Eng J Med 2001;344:1132–8
   PubMed Web of Science ®Google Scholar
• Thomas SV, Ajaykumar B, Sindhu K, et al. Cardiac malformations are increased in infant of mothers with epilepsy. Pediatr Cardiol 2008;29:604–8
   PubMedGoogle Scholar
• Czeizel AE, Bánhidy F. Congenital abnormalities of children born to epileptic women treated with antiepileptic drugs in Hungary –a population-based study. The Open Drug Safety J (TODSJ) 2010;1:40–56
   Google Scholar
• Bánhidy F, Ács N, Puhó HE, Czeizel AE. Paroxysmal supraventricular tachycardia in pregnant women and birth outcomes of their children. Am J Med Genet 2010;150A:380–8
   Google Scholar
• Czeizel AE, Dudás I. Prevention of first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832–5
   PubMed Web of Science ®Google Scholar
• Czeizel AE. Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am J Med Genet 1996;62:179–83
   PubMed Web of Science ®Google Scholar
• Czeizel AE, Dobó M, Vargha P. Hungarian cohort-controlled trial of periconceptional multivitamin supplementation shows a reduction in certain congenital abnormalities. Birth Defects Res Part A 2004;70:853–61
   PubMed Web of Science ®Google Scholar
• Czeizel AE. Periconceptional folic acid and multivitamin supplementation for the prevention of neural tube defects and other congenital abnormalities. Birth Defects Res Part A 2009;85:260–8
   PubMed Web of Science ®Google Scholar
• Botto LD, Khoury MJ, Mulinare J, Erickson JD. Periconceptional multivitamin use and occurrence of conotruncal heart defects: results from a population-based, case-control study. Pediatrics 1996;9:911–7
   Google Scholar
• Botto LD, Olney RS, Erickson JD. Vitamin supplements and the risk for congenital anomalies other than neural-tube defects. Am J Med Genet 2004;125:12–21
   Google Scholar
• Botto LD, Mulinare J, Erickson JD. Occurrence of congenital heart defects in relation to maternal multivitamin use. Am J Epidemiol 2000;151:878–84
   PubMed Web of Science ®Google Scholar
• Botto LD, Mulinary J, Erickson JD. Do multivitamin or folic acid supplements reduce the risk for congenital heart defects? Am J Med Genet 2003;121A:95–101
   PubMed Web of Science ®Google Scholar
• Czeizel AE, Toth M, Rockenbauer M. A case-control analysis of folic acid supplementation during pregnancy. Teratology 1996;53:345–51
   PubMedGoogle Scholar
• van Beynum IM, Kapusta L, Bakker MK, et al. Protective effect of periconceptional folic acid supplements on the risk of congenital heart defects: a registry-based case-control study in the northern Netherlands. Eur Heart J 2010;31:464–71
   PubMed Web of Science ®Google Scholar
• Kapusta L, Haagmans ML, Steegers EA,, et al. Congenital heart defects and maternal derangement of homocysteine metabolism J Pediatr 1999;135:773–4
   PubMed Web of Science ®Google Scholar
• Wenstrom KD, Johanning GL, Johnston KE, DuBard M. Association of the C677T methylenetetrahydrofolate reductase mutation an elevated homocysteine levels with congenital cardiac malformations. Am J Obstet Gynecol 2001;184:806–12
   PubMed Web of Science ®Google Scholar
• Junker R, Kotthoff S, Vielhaber J, et al. Infant methylenetetrahydrofolate reductase 677TT genotype is a risk factor for congenital heart disease. Cardiovasc Res 2001;51:151–4
   PubMed Web of Science ®Google Scholar
• Hobbs CA, Cleves MA, Karim MA. Maternal folate-related gene environment interactions and congenital heart defects. Obstet Gynecol 2010;116:316–22
   PubMed Web of Science ®Google Scholar
• Ács N, Bánhidy F, Puhó E, Czeizel AE. Maternal severe migraine and risk of limb deficiencies. Birth Defects Res Part A 2006;76:592–601
   PubMed Web of Science ®Google Scholar
• Czeizel AE, Ács N, Bánhidy F. Migraine in pregnant women. Trends Reprod Biol 2008;3:1–8
   Google Scholar
• Källen BAJ, Olausson PO. Maternal drug use in early pregnancy and infant cardiovascular defect. Reprod Toxicol 2003;17:255–61
   PubMed Web of Science ®Google Scholar
• Nora JJ. From generational studies to a multilevel genetic-environmental interaction. J Am Coll Cardiol 1994;23:1468–71
   PubMed Web of Science ®Google Scholar
• Mészáros M, Czeizel AE. ECG conduction disturbance in the first-degree relatives of children with ventricular septal defect. Hum Hered 1981;19:298–301
   Google Scholar
• Rockenbauer M, Olsen J, Czeizel AE, et al. Recall bias in a case-control study on the use of medicine during pregnancy. Epidemiology 2001;12:401–66
   Web of Science ®Google Scholar
• Khoury MJ, James LM, Erickson JD. On the use of affected controls to address recall bias in case-control studies of birth defects. Teratology 1994;49:273–81
   PubMedGoogle Scholar